Long Gao
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Evaluation and investigation of the cardiotoxicity of the potential anti-cholangiocarcinoma drug lanatoside C.
Journal: Frontiers in toxicology
Published: January 08, 2026
CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations.
Journal: Human cell
Published: November 06, 2025
Denture use is associated with a higher risk of cholelithiasis: a prospective cohort study.
Journal: BMC oral health
Published: October 06, 2025
Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity.
Journal: Acta pharmaceutica Sinica. B
Published: April 10, 2025
Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in Cholangiocarcinoma.
Journal: Molecular & cellular proteomics : MCP
Published: April 04, 2025
Real-time diagnosis of cholangiocarcinoma by combining digestive endoscopy and optic fiber biosensors based on bile clusterin.
Journal: Med (New York, N.Y.)
Published: March 19, 2025
Ti3C2 MXene/GNRs for synergistically highly enhanced sensitivity of optical fiber SPR acetylcholine biosensors via an electrostatic layer-by-layer assembly method.
Journal: Biosensors & bioelectronics
Published: July 23, 2024
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6.
Journal: Scientific reports
Published: June 27, 2024
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia.
Journal: Pharmacological research
Published: May 31, 2024
Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
Journal: BMC medicine
Published: April 28, 2024
Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.
Journal: Medical review (2021)
Published: March 27, 2024
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing.
Journal: Acta pharmaceutica Sinica. B
Published: February 20, 2024
Last Updated: 09/26/2026